Please use this identifier to cite or link to this item: https://doi.org/10.1128/AAC.00469-17
DC FieldValue
dc.titleAntimicrobial activity and cell selectivity of synthetic and biosynthetic cationic polymers
dc.contributor.authorVenkatesh, M
dc.contributor.authorBarathi, V.A
dc.contributor.authorGoh, E.T.L
dc.contributor.authorAnggara, R
dc.contributor.authorFazil, M.H.U.T
dc.contributor.authorNg, A.J.Y
dc.contributor.authorHarini, S
dc.contributor.authorAung, T.T
dc.contributor.authorFox, S.J
dc.contributor.authorLiu, S
dc.contributor.authorYang, L
dc.contributor.authorBarkham, T.M.S
dc.contributor.authorLoh, X.J
dc.contributor.authorVerma, N.K
dc.contributor.authorBeuerman, R.W
dc.contributor.authorLakshminarayanan, R
dc.date.accessioned2020-10-23T02:38:52Z
dc.date.available2020-10-23T02:38:52Z
dc.date.issued2017
dc.identifier.citationVenkatesh, M, Barathi, V.A, Goh, E.T.L, Anggara, R, Fazil, M.H.U.T, Ng, A.J.Y, Harini, S, Aung, T.T, Fox, S.J, Liu, S, Yang, L, Barkham, T.M.S, Loh, X.J, Verma, N.K, Beuerman, R.W, Lakshminarayanan, R (2017). Antimicrobial activity and cell selectivity of synthetic and biosynthetic cationic polymers. Antimicrobial Agents and Chemotherapy 61 (10). ScholarBank@NUS Repository. https://doi.org/10.1128/AAC.00469-17
dc.identifier.issn0066-4804
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/179258
dc.description.abstractThe mammalian and microbial cell selectivity of synthetic and biosynthetic cationic polymers has been investigated. Among the polymers with peptide backbones, polymers containing amino side chains display greater antimicrobial activity than those with guanidine side chains, whereas ethylenimines display superior activity over allylamines. The biosynthetic polymer ε-polylysine (εPL) is noncytotoxic to primary human dermal fibroblasts at concentrations of up to 2,000 μg/ml, suggesting that the presence of an isopeptide backbone has greater cell selectivity than the presence of α-peptide backbones. Both εPL and linear polyethylenimine (LPEI) exhibit bactericidal properties by depolarizing the cytoplasmic membrane and disrupt preformed biofilms. εPL displays broad-spectrum antimicrobial properties against antibiotic-resistant Gram-negative and Gram-positive strains and fungi. εPL elicits rapid bactericidal activity against both Gram-negative and Gram-positive bacteria, and its biocompatibility index is superior to those of cationic antiseptic agents and LPEI. εPL does not interfere with the wound closure of injured rabbit corneas. In a rabbit model of bacterial keratitis, the topical application of εPL (0.3%, wt/vol) decreases the bacterial burden and severity of infections caused by Pseudomonas aeruginosa and Staphylococcus aureus strains. In vivo imaging studies confirm that εPL-treated corneas appeared transparent and nonedematous compared to untreated infected corneas. Taken together, our results highlight the potential of εPL in resolving topical microbial infections. © 2017 Venkatesh et al.
dc.publisherAmerican Society for Microbiology
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectallylamine
dc.subjectantiinfective agent
dc.subjectaziridine
dc.subjectbenzalkonium chloride
dc.subjectchlorhexidine
dc.subjectepsilon polylysine
dc.subjectguanidine
dc.subjectpolyethyleneimine
dc.subjectpolylysine
dc.subjectpolymer
dc.subjecttobramycin
dc.subjectunclassified drug
dc.subjectallylamine
dc.subjectantiinfective agent
dc.subjectantimicrobial cationic peptide
dc.subjectaziridine derivative
dc.subjectpolyethyleneimine
dc.subjectpolylysine
dc.subjectpolymer
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectantimicrobial activity
dc.subjectArticle
dc.subjectbacterial keratitis
dc.subjectbacterial strain
dc.subjectbactericidal activity
dc.subjectbiocompatibility
dc.subjectbiofilm
dc.subjectcell membrane
dc.subjectcontrolled study
dc.subjectcornea
dc.subjectcornea injury
dc.subjectfibroblast
dc.subjectfungus
dc.subjectGram negative bacterium
dc.subjectGram positive bacterium
dc.subjecthuman
dc.subjecthuman cell
dc.subjectin vivo study
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectPseudomonas infection
dc.subjectStaphylococcus infection
dc.subjectwound closure
dc.subjectanimal
dc.subjectCandida albicans
dc.subjectcandidiasis
dc.subjectcell line
dc.subjectchemistry
dc.subjectdisease model
dc.subjectdrug effect
dc.subjectkeratitis
dc.subjectLeporidae
dc.subjectmicrobial sensitivity test
dc.subjectmicrobiology
dc.subjectPseudomonas aeruginosa
dc.subjectPseudomonas infection
dc.subjectStaphylococcus aureus
dc.subjectStaphylococcus infection
dc.subjectAllylamine
dc.subjectAnimals
dc.subjectAnti-Bacterial Agents
dc.subjectAntimicrobial Cationic Peptides
dc.subjectAziridines
dc.subjectCandida albicans
dc.subjectCandidiasis
dc.subjectCell Line
dc.subjectCell Membrane
dc.subjectDisease Models, Animal
dc.subjectFibroblasts
dc.subjectHumans
dc.subjectKeratitis
dc.subjectMicrobial Sensitivity Tests
dc.subjectPolyethyleneimine
dc.subjectPolylysine
dc.subjectPolymers
dc.subjectPseudomonas aeruginosa
dc.subjectPseudomonas Infections
dc.subjectRabbits
dc.subjectStaphylococcal Infections
dc.subjectStaphylococcus aureus
dc.typeArticle
dc.contributor.departmentMATERIALS SCIENCE AND ENGINEERING
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.contributor.departmentOPHTHALMOLOGY
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1128/AAC.00469-17
dc.description.sourcetitleAntimicrobial Agents and Chemotherapy
dc.description.volume61
dc.description.issue10
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1128_AAC_00469-17.pdf3.02 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons